Intelligence · Clinical Development
Pipeline search results
Programs matching “eli lilly” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 169 pipeline programs matching "eli lilly" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
0.9% sodium chloride, Lepodisiran
Eli Lilly Co.
Atherosclerotic Cardiovascular Disease Elevated lp(a)
1 trial -
14V-MC-JAJK
Eli Lilly Co.
Diabetes Mellitus, Type 1
1 trial -
5 mg Tadalafil
Eli Lilly and Company
Benign Prostate Hyperplasia
1 trial -
ABEMACICLIB , FULVESTRANT
Eli Lilly Co.
Breast cancer
1 trial -
Abemaciclib
Eli Lilly and Company
Breast Cancer
1 trial -
Abemaciclib
Eli Lilly and Company
Non Small Cell Lung Cancer
1 trial -
Baricitinib
Eli Lilly Co.
Covid19 Corona Virus Infection
1 trial -
Baricitinib
Eli Lilly and Company
Systemic Lupus Erythematosus
1 trial -
Baricitinib
Eli Lilly and Company
Systemic Juvenile Idiopathic Arthritis
1 trial -
Clopidogrel
Eli Lilly and Company
Acute Coronary Syndrome
1 trial -
Drotrecogin alfa (activated)
Eli Lilly and Company
Sepsis
1 trial -
Duloxetine hydrochloride
Eli Lilly and Company
Diabetic Neuropathies
1 trial -
Eloralintide
Eli Lilly and Company
Obesity
1 trial -
Galcanezumab, Placebo to match LY2951742
Eli Lilly Co.
Migraine
1 trial -
Galcanezumab, Placebo to match LY2951742
Eli Lilly Co.
Chronic Migraine
1 trial -
Glargine
Eli Lilly and Company
Diabetes Mellitus, Type 2
1 trial -
H8H-MC-LAHV
Eli Lilly Co.
Migraine
1 trial -
Human Insulin Inhalation Powder
Eli Lilly and Company
Diabetes Mellitus
1 trial -
I3Y-MC-JPCF
Eli Lilly Co.
Breast Cancer
1 trial -
I3Y-MC-JPCM
Eli Lilly Co.
Prostate Cancer
1 trial -
I3Y-MC-JPEF
Eli Lilly Co.
Breast Neoplasm, Neoplasm Metastasis
1 trial -
I4V-MC-JAHU
Eli Lilly Co.
Systemic Juvenile Idiopathic Arthritis
1 trial -
I4V-MC-JAHW
Eli Lilly Co.
Uveitis
1 trial -
I4V-MC-JAHX
Eli Lilly Co.
Juvenile Idiopathic Arthritis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.